NCT06940349View on ClinicalTrials.gov

Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions
Solid Tumors Refractory to Standard Therapy
Interventions
DRUG

Palbociclib

Palbociclib and Sunitinib

DRUG

Sunitinib

Palbociclib and Sunitinib

Trial Locations (1)

Unknown

RECRUITING

Davidoff cancer center, RMC, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER